News

Novo Nordisk, Eli Lilly face first major obesity drug rival in China as Innovent gains approval for mazdutide
Novo Nordisk (NVO) and Eli Lilly & Co. (LLY), the global leaders in obesity medications, are now facing their first major ...
Class Action Announcement HIMS: A Securities Fraud Class Action Lawsuit Was Filed Against Hims & Hers Health, Inc. (HIMS)
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Hims & Hers losses, you mayCLICK HERE or copy and paste the following link into your browser: ...
Notable healthcare headlines for the week: Novo Nordisk, Amgen and UnitedHealth in focus
Wall Street’s major averages closed Friday's trading session higher, as both the S&P 500 (SP500) and Nasdaq Composite ...
Top global stories this week: Shell, Novo Nordisk among notable names
Both the S&P 500 ( SP500) and Nasdaq Composite ( COMP:IND) notched fresh all-time trading highs and record high closes on Friday. At the end of the week, both S&P 500 and the Dow Jones ( DJI) gained 3 ...